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Toxoplasma gondii is a protozoan pathogen in the
phylum Apicomplexa that resides within an intracel-
lular parasitophorous vacuole (PV) that is selectively
permeable to small molecules through unidentified
mechanisms. We have identified GRA17 as a Toxo-
plasma-secreted protein that localizes to the parasi-
tophorous vacuole membrane (PVM) and mediates
passive transport of small molecules across the
PVM. GRA17 is related to the putative Plasmodium
translocon protein EXP2 and conserved across PV-
residing Apicomplexa. The PVs of GRA17-deficient
parasites have aberrant morphology, reduced
permeability to small molecules, and structural insta-
bility. GRA17-deficient parasites proliferate slowly
and are avirulent in mice. These GRA17-deficient
phenotypes are rescued by complementation with
Plasmodium EXP2. GRA17 functions synergistically
with a related protein, GRA23. Exogenous expres-
sion of GRA17 or GRA23 alters the membrane
conductance properties of Xenopus oocytes in a
manner consistent with a large non-selective pore.
Thus, GRA17 and GRA23 provide a molecular basis
for PVM permeability and nutrient access.
INTRODUCTION
Protozoan parasites in the phylum Apicomplexa present a
global human and veterinary health problem. Toxoplasma gon-
dii, which causes toxoplasmosis, can infect a wide range of
warm-blooded animals including humans and is a particular
challenge to immune-compromised individuals such as AIDS642 Cell Host & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Ipatients and fetuses of infected mothers. Apicomplexan para-
sites spend the majority of their life cycle within host cells
and have evolved diverse strategies to survive in this niche.
Many, like Toxoplasma and Plasmodium, reside within a non-
fusogenic parasitophorous vacuole (PV). The PV membrane
(PVM) is the physical interface between PV-residing parasites
and their host cells during intracellular growth, remaining intact
until parasite egress. The PV protects parasites from being
sensed by the host cell, but it is also a potential barrier to the
scavenging of nutrients from the host and to parasite effectors
accessing the host.
Apicomplexan parasites depend on host cells for many essen-
tial nutrients. For instance, Toxoplasma is auxotrophic for small
molecules including amino acids like tryptophan and arginine,
purines, and sterols (reviewed in Coppens, 2014). Some, like ste-
rols, are actively scavenged from the host cell to the PV through
sterol transporters on the PVM (Ehrenman et al., 2010). Trans-
porters for small metabolites have been identified on the Toxo-
plasma plasma membrane but not on the PVM (Landfear,
2011). The Toxoplasma, Plasmodium, and Eimeria PVMs are
selectively permeable, allowing passive, charge-independent
diffusion of small molecules up to 1,300–1,900 Da into the PV,
presumably through pore-like molecules on the PVM (Desai
and Rosenberg, 1997; Schwab et al., 1994; Werner-Meier and
Entzeroth, 1997). This is the putative mechanism by which the
parasite within the PV gains access to host metabolites or
effluxes toxic metabolic byproducts like lactate into the host
cell. The molecular identity of the pores that grant this PVM
permeability is unknown.
Toxoplasma partially circumvents the PVMbarrier by secreting
proteins into the host cell before and during invasion before
formation of the PV from secretory organelles that include rhop-
tries and dense granules. Secreted effectors play a critically
important role in Toxoplasma pathogenesis, modulating host
signaling and creating a hospitable environment in the PV (re-
viewed in Hunter and Sibley, 2012; Kemp et al., 2013). Unlikenc.
Table 1. GRA17-Like Genes Are Unique to PV-Residing Apicomplexa
Organism GRA17-Like Genes Gene Names PV?
Toxoplasma gondii 2 GRA17 (TGGT1_222170), GRA23 (TGGT1_297880) yes
Neospora caninum 2 NCLIV_005560, NCLIV_006780 yes
Hammondia hammondi 2 HHA_222170, HHA_297880 yes
Sarcocystis spp. 2 S. neurona Aa, S. neurona B; S. muris DG32b yes
Eimeria spp. 1 E. acervulina EAH_00026470 (DG32) and E. mitis EMH_0012530 (DG32)c yes
Plasmodium spp. 1 P. falciparum PF3D7_1471100 (EXP2), P. knowlesi PKH_123420 (EXP2),
P. reichenowi PRCDC_1470300 (EXP2)
yes
Babesia bovis 0 NA no
Cryptosporidium spp. 0 NA no
Theileria spp. 0 NA no
Gregarina niphandrodes 0 NA no
The peptide sequences of GRA17 and GRA23 were used as bait in searches against apicomplexan organisms in EuPathDB.org using the BLASTP 2.0
algorithm or TBLASTN 2.2.26. Subsequent hits receiving a p value less than 0.005 were identified as similar to GRA17 and themselves used as baits in
subsequent searches.
aThe S. neurona genome is sequenced but unannotated, so the two GRA17-like genes were arbitrarily named ‘‘A’’ and ‘‘B.’’
bThe S. muris genome has not been sequenced, so we cannot determine whether there is a second GRA17-like gene.
cGRA17-like genes were identified for all Eimeria and Plasmodium species whose genomes have been sequenced, but for brevity, only a selection of
these were included in this table.the invasion-secreted rhoptry proteins (ROPs), dense granule
proteins (GRAs) are also secreted post-invasion (Karsten et al.,
1998).
Plasmodium exports proteins beyond its PVM into the erythro-
cyte cytosol. EXP2 is the putative protein-conducting pore of the
Plasmodium translocon for exported proteins (PTEX) complex
that mediates the essential export of secreted proteins contain-
ing a Plasmodium export element (PEXEL) sequence motif (de
Koning-Ward et al., 2009). There are also PEXEL-independent
mechanisms of protein export (Gru¨ring et al., 2012; Siau et al.,
2014) that utilize the same PTEX machinery (Beck et al., 2014;
Elsworth et al., 2014). In Toxoplasma, post-invasion protein
export into the host cell has only been reported for GRA16 and
GRA24 (Bougdour et al., 2013; Braun et al., 2013). Most charac-
terized Toxoplasma GRA proteins are involved in organizing the
structure and environment of the PV or associated with the PVM,
but others such as GRA15, GRA16, and GRA24 play a role
in modulating host cell signaling, suggesting that there may be
more GRA proteins trafficked beyond the PVM after invasion
(Bougdour et al., 2013; Mercier et al., 2005; Rosowski et al.,
2011).
We sought to investigate the molecular interaction between
the Toxoplasma PV and the host cell by studying a PVM-local-
ized GRA protein with homology to Plasmodium EXP2.
RESULTS
GRA17 Is a Secreted GRA Protein Required for Normal
PV Morphology
Since EXP2 has been implicated in forming a molecular-translo-
cation channel in the P. falciparum PVM, we searched for homo-
logs in the Toxoplasma genome and found two genes encoding
proteins with predicted signal peptides: the uncharacterized
TGGT1_222170 and TgGRA23 (TGGT1_297880), an identified
GRA gene of unknown function (Masatani et al., 2013).
TGGT1_222170 and TgGRA23 share 30% amino acid sequenceCell Hsimilarity with each other and 26% and 22% similarity with
PfEXP2, respectively (Figure S1A). Homologs of these proteins,
including Sarcocystis muris DG32 (Freyer et al., 1999), were
identified only in Apicomplexa that replicate within a PV (Table 1).
Except for Plasmodium spp. EXP2, none of these genes have
been functionally characterized, but due to its similarity to
GRA23, we provisionally named TGGT1_222170, ‘‘GRA17.’’
There is only one gene similar to TgGRA17 or TgGRA23 found
in Eimeria spp. and Plasmodium spp., but we found two distinct
homologs in the genomes of other sequenced PV-residing
Apicomplexa that are grouped in the family Sarcocystidae
(Table 1; Figure S1B). We found that GRA17 and GRA23 are
conserved proteins with high gene transcription levels across a
global range of Toxoplasma strains (Melo et al., 2013; Minot
et al., 2012).
Besides strongly predicted a helices, GRA17 and GRA23 lack
sequence motifs that suggest a functional role. To characterize
them, we individually disrupted the GRA17 and GRA23 genes
andwe complemented theDGRA17 strain with either HA-tagged
GRA17 or Toxoplasma-codon-optimized P. falciparum EXP2
transgenes that we will refer to as ‘‘DGRA17+GRA17-HA’’ and
‘‘DGRA17+PfEXP2-HA’’ (Figures S2A–S2E). The DGRA17 strain
was also complemented with GRA23-HA-FLAG (HF) expressed
from either the putative gra23 promoter ‘‘DGRA17+GRA23-
HFlow’’ or from the strong gra1 promoter ‘‘DGRA17+GRA23-
HFhigh’’; the differing expression levels in these strains were
verified bywestern blot (Figure S2F).We infected human foreskin
fibroblasts (HFFs) with tachyzoites (the fast-replicating stage of
Toxoplasma), fixed, and analyzed the sample by deconvolution
immunofluorescence (IF) microscopy. TheDGRA17+GRA17-HA
strain was used for many co-staining experiments as it does not
express GFP, and the GRA17-HA localization was invariant
across all the strains (data not shown). We observed that
GRA17-HA is intra-vacuolar and is associated with the PVM
and possibly the tubulo-vesicular network (TVN) based on its
partial co-localization with GRA7 (a PVM and TVN marker) andost & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Inc. 643
Figure 1. GRA17 Associates with the PVM
and Affects PV Morphology
(A) HFFs were infected with the indicated Toxo-
plasma tachyzoite strains for 24 hr, fixed, and
subjected to IF with the antibodies indicated.
The WT+GRA17-V5/GRA23-HA-FLAG also ex-
presses cytosolic GFP. The fluorescent images
represent a single deconvoluted focal slice.
Bright-field images were taken with differential
interference contrast (DIC) microscopy (scale
bar = 10 mm).
(B) HFFs were infected with WT+GRA17-HA ta-
chyzoites for 24 hr and mechanically lysed, and a
membrane-enriched fraction was treated with
either PBS or sodium carbonate, centrifuged to
obtain pelleted (P) and soluble (S) fractions, and
subjected to SDS-PAGE. The fractions were
western blotted as indicated.
(C) HFFs were infected with the indicated strains
for 36 hr and imaged live by phase contrast mi-
croscopy (scale bar = 25 mm).GRA4 (a TVN marker) especially around the periphery of the PV
(Figure 1A). GRA23 has previously been characterized as a PVM-
localized GRA (Masatani et al., 2013), and to observe its relative
co-localization with GRA17, we generated a strain that co-ex-
presses GRA17-V5 and GRA23-HF (the tachyzoites express
GFP) and observed substantial co-localization around the PVM
(Figures 1A, bottom panel, and S2G); however, the localization
of GRA17-HA appeared localized to discrete foci relative to the
more continuous pattern of GRA23-HF around the PVM.
PfEXP2-HA localized to the PVM in the DGRA17 strain, and the
localization of GRA23-HF was unaffected by the absence of
GRA17 in the DGRA17+GRA23-HFlow strain (Figure S2H). We
confirmed that GRA17 is a GRA by observing partial co-localiza-
tion of GRA17 and GRA7 in extracellular tachyzoites (Figure S2I).
We raised a specific antibody against GRA17 that detected a
19 kDa band that is absent in the DGRA17 strain (Figure S3A,
lanes 1–4).
We tested GRA17 association with the PVM by fractionating
HFFs infected with WT+GRA17-HA by ultracentrifugation
and extracting a membrane-enriched fraction with either PBS
or sodium carbonate. Sodium carbonate treatment extracts
peripherally attached proteins such as GRA1, but more tightly
membrane-associated proteins like GRA7 remain in the insol-
uble fraction (Neudeck et al., 2002; Sibley et al., 1995). We found
that in contrast to GRA1, GRA17was onlyminimally extracted by
sodium carbonate and that themajority remained in the insoluble
fraction (Figure 1B). Thus, the majority of GRA17 is tightly asso-644 Cell Host & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Inc.ciated with the PVM. A similar fraction-
ation pattern for GRA23 has been re-
ported (Masatani et al., 2013).
We observed that a significant portion
of PVs in the DGRA17 strain were grossly
enlarged relative to the number of para-
sites in the PV, whereas the DGRA23
PVs are similar to wild-type (WT) (Fig-
ure 1C). Furthermore, the DGRA17-com-
plemented strains, DGRA17+GRA17-HAand DGRA17+PfEXP2-HA, completely rescued this aberrant
morphology. We were unable to generate a DGRA17/DGRA23
strain, but we were able to delete the GRA23 gene from the
DGRA17+GRA17-HA strain, which has low GRA17 expres-
sion (Figure S3A, lanes 2 and 8). We observed that this
DGRA17/DGRA23+GRA17-HA strain mimics the aberrant PV
morphology of the DGRA17 strain (Figure 1C), providing evi-
dence of functional overlap between GRA17 and GRA23.
Furthermore, the DGRA17 strain complemented with high
(but not lower) expression of GRA23-HF partially suppressed
this phenotype, with infrequent enlarged vacuoles observed
(Figure 1C).
We examined whether there were other genes involved in
a compensatory role with the DGRA17 strain by sequencing
the total mRNA from bone-marrow-derived mouse macro-
phages 4 hr post-infection with WT, DGRA17, DGRA23, and
DGRA17+GRA17-HA strains and mapping the sequences
to the Toxoplasma genome. As previously observed, GRA17
expression in the DGRA17+GRA17-HA strain was 2.5-
fold less compared to WT despite its ability to functionally
rescue the DGRA17 strain (Figure S3B) (GEO: GSE65980).
GRA23 expression levels in the DGRA17 strain were 1.8-fold
increased over WT levels, and GRA17 levels were not
increased in the DGRA17 strain (Figure S3B). We found five
additional, uncharacterized putative signal peptide-containing
proteins that were uniquely upregulated in the DGRA17 strain
(Table S2).
Figure 2. GRA17 IsRequired for the Transfer
of Small Molecules into the PV
(A) Indicated tachyzoite strains endogenously
tagged with GRA24-HA-FLAG were used to infect
HFFs, and the samples were fixed at the indicated
time points, stained with Hoechst dye (red) and
anti-HA (green), and overlaid onto a DIC image. For
each channel, the exposure time is the same. This
experiment was performed twice.
(B) Sub-confluent HFFs were infected with the
indicated strains for 24 hr after which they were
pulse labeled with CDCFDA (green) for 10 min
before the cells were imaged live. White arrows
indicate intra-vacuolar fluorescence and the red
arrow indicates the absence of intra-vacuolar
fluorescence (left panel; scale bars = 10 mm). The
percentage of CDCF-fluorescent vacuoles was
quantified for each strain and averaged across
experiments (right panel). A minimum of 50 vacu-
oles per strain was counted for each replicate.
Error bars represent ± SD, and the numbers above
the bars of the graph indicate the number of
experimental replicates for each condition. Un-
paired two-tailed t tests compared to WT (***p =
3 3 107; **p = 0.002) or DGRA17 (### p %
0.00001; ##p = 0.01) were performed.
(C) Confluent HFFs were infected with the indi-
cated strains for 24 hr after which either lucifer
yellow or Dextran3000-Alexa 488 were scrape-
loaded into the cells and imaged live immediately.
Intra-PV fluorescence was scored relative to the
fluorescence of the individual host cell as present,
intermediate, or absent as a percentage of total
vacuoles (Figure S3D) and averaged across three
experimental replicates (error bars are ± SD).GRA17 Is Involved in the Movement of Small Molecules
between the Host and PV
Since PfEXP2 can rescue a DGRA17 phenotype, we wondered
whether GRA17 or GRA23 plays a role in protein export
beyond the PVM. The GRA proteins GRA16 and GRA24
localize to the host nucleus with increasing intensity over
the time of infection, peaking at 20 hr, indicating that they
are exported across the PVM after the PV has been formed
(Bougdour et al., 2013; Braun et al., 2013). We tagged the
endogenous copy of GRA24 with HA-FLAG (HF) in the WT,
DGRA17, and DGRA23 strains. We also transiently trans-
formed GRA16-HF into WT, DGRA17, and DGRA23 extracel-
lular tachyzoites with which we immediately infected HFFs.
We then fixed the infected cells at early and late time points
post-infection. Across all strains we observed a temporal in-
crease from low to high levels of GRA16-HF and GRA24-HF
staining in the host nucleus (Figures 2A and S3C). Thus, neitherCell Host & Microbe 17, 642–GRA17 nor GRA23 are individually
required for GRA16 and GRA24 export
beyond the PVM.
While GRA17 and GRA23 do not
appear to affect protein transport across
the PVM, we asked if they function as a
pore for small molecules andmetabolites.
We used the properties of the vital dye 5-(and-6)-carboxy-20,70-dichlorofluorescein diacetate (CDCFDA)
to test this hypothesis. CDCFDA is membrane permeable and
non-fluorescent until it enters living cells, where intracellular es-
terases convert it into the fluorescent, membrane-impermeable
5-(and-6)-carboxy-20,70-dichlorofluorescein (CDCF). The molec-
ular weight of the CDCF fluorophore (445.2 Da) is less than the
established size-exclusion limit of the ToxoplasmaPVM (Schwab
et al., 1994), so we predicted that it should passively enter into
the PV through the PVM but be unable to permeate through
the tachyzoite plasma membrane (Schwab et al., 1994). We
infected HFFs with the WT, DGRA17, DGRA17+GRA17-HA,
DGRA23, DGRA17+PfEXP2-HA, DGRA17/DGRA23+GRA17-
HA, and DGRA17+GRA23-HFlow/high strains for 24 hr and then
added a pulse of CDCFDA to the cell culture medium before
washing away the dye and subsequently imaging the living
cells. As predicted, we observed CDCF-fluorescence intensity
equivalent to the host cytosol within nearly all the PVs of the652, May 13, 2015 ª2015 Elsevier Inc. 645
WT, DGRA17+GRA17-HA, DGRA17+PfEXP2-HA, and DGRA23
strains but excluded from the tachyzoites themselves (Figure 2B,
white arrows). By contrast, 36% of the PVs in the DGRA17 strain
had equivalent intra-PV CDCF-fluorescence compared to the
host cytosol (p = 4 3 108 to WT; Figure 2B, red arrow and right
panel), suggesting a role for GRA17 involving the passage of
small molecules into the PV. We observed a similar phenotype
for the DGRA17/DGRA23+GRA17-HA strain, with CDCF-
fluorescence in 51% of PVs (p = 0.002 to WT and no statistical
difference to DGRA17; Figure 2B, right panel). In contrast to
the DGRA17+GRA23-HFlow strain, which was similar to the
DGRA17 strain (45% intra-PV CDCF-fluorescence; p = 0.002
from WT), we observed a partial rescue of dye transfer with the
DGRA17+GRA23-HFhigh strain with CDCF fluorescence in 73%
of PVs that was statistically distinct from the DGRA17 strain
(p = 0.01; Figure 2B), further suggesting a synergistic role for
GRA23 in small molecule permeability. Since we observed PVs
of varying permeability within the same host cell (Figure 2B,
DGRA17), the GRA17-mediated effect on PVM permeability to
the small molecule fluorophore is PV autonomous and indepen-
dent of host intracellular fluorophore concentration.
We confirmed this phenotype by introducing the membrane-
impermeable dyes lucifer yellow (522 Da) or Dextran (3,000
Da)-Alexa-488 into infected cells by the technique of scrape-
loading (McNeil et al., 1984). Since cellular dye uptake varies
around the scrape, there was a large degree of heterogeneity
of both intracellular and intra-PV dye intensities. We scored the
intra-PV dye intensity relative to its host cell dye intensity as
‘‘present,’’ ‘‘absent,’’ or ‘‘intermediate’’ (Figure S3D). We found
that the scrape-loaded lucifer yellow results were similar to
the CDCFDA results: in contrast to >90% of WT, DGRA17+
GRA17-HA, and DGRA23 PVs, only 22% of DGRA17 PVs were
scored as having fluorescence fully equivalent to their host cells
(Figure 2C). When the larger dextran (3,000 Da) dye was scrape-
loaded into infected cells, we found that most of the PVs of
both WT and DGRA17 failed to uptake the dye, consistent with
the established Toxoplasma PVM size-exclusion limit (Schwab
et al., 1994). These results provide further evidence that PfEXP2
can rescue DGRA17 phenotypes and for functional overlap
between GRA17 and GRA23.
The Absence of GRA17 Results in Highly Dynamic,
Unstable PV
We found that fixatives altered the appearance and numbers of
the enlarged, aberrant DGRA17 PVs (data not shown), so we
imaged the DGRA17 strain live over an extended time period
post-infection to observe the dynamics of these PVs. Nearly all
of the PVs we observed by live imaging appeared enlarged at
some point during the experimental time course. We also
observed many enlarged PVs ‘‘collapsing,’’ where the tachy-
zoites within them turn opaque and cease to divide. As an
example, we present a multiple infected host cell where all but
one PV collapses over a 5:30 hr time course (Figure 3A; Movie
S1). The remaining intact PV within this cell remained enlarged
and continued to divide, ultimately egressing from the cell at
62:00 hr (Movie S2). We have also observed PV collapse in singly
infected cells (Figure S4A). Furthermore, we observed dynamic
alteration of the size and shape of the vacuoles as exemplified
by a PV that becomes grossly enlarged to the size of the entire646 Cell Host & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Ihost cell before ultimately egressing (Figure S4B; Movies S3
and S4). Since the tachyzoites within these enlarged PVs divide
normally and we regularly observe egress, it indicates that they
are viable.
In concordance with the PV collapse, we observed that
DGRA17 tachyzoites grew more slowly than WT tachyzoites.
We measured this effect by quantifying the mean area of
plaques formed in HFF monolayers by infection with the
DGRA17 and DGRA23 strains relative to WT. These assays
measure the overall growth of the parasites in vitro. We found
that DGRA17 formed plaques that were 53% the size of the
WT strain (p < 0.0001; Figures 3B and S5A), and the DGRA17+
GRA17-HA strain fully rescued this growth defect. The DGRA23
strain formed plaques that were slightly smaller than the WT
strain, but this effect was not significant (p = 0.21; Figures 3B
and S5A). In contrast to the smaller plaques made by the
DGRA17 strain, we observed that a strain that overexpresses
GRA17-HA (WT+GRA17-HA; Figure S3A, lanes 9 and 10)
formed plaques that were 67% larger than WT (p < 0.0001; Fig-
ures 3B and S5A), implying that excess GRA17 can accelerate
growth of the parasite. The collapsed PVs with non-dividing
tachyzoites suggest a basis for the slow growth of the
DGRA17 strain in vitro.
GRA17 and GRA23 Affect the In Vivo Growth and
Virulence of Toxoplasma
We examined whether the effects of GRA17 on overall
Toxoplasma proliferation in vitro would manifest in vivo. We in-
fected CD-1 outbred mice intraperitoneally (i.p.) with 100 tachy-
zoites of the WT, DGRA17, DGRA17+GRA17-HA, and DGRA23
strains. We also infected an additional cohort with 1,000 tachy-
zoites of the DGRA17 strain. None of the mice infected with
the WT, DGRA23, and DGRA17+GRA17-HA strains survived
beyond 12 days post-infection (Figure 4A), consistent with the
reported hyper-virulence of the type I genetic background of
our strains (LD100 = 1 tachyzoite). By contrast, all of the
mice infected with either the low or high dose of the DGRA17
tachyzoites survived. All of these mice were seropositive and
were resistant to subsequent challenge with 10,000 WT (type I)
tachyzoites (Figure 4A, arrow). Subsequently, we infected
cohorts of CD-1 mice with 100 tachyzoites each of the
DGRA17, DGRA17+GRA17-HA, DGRA17+PfEXP2-HA, and
DGRA17/DGRA23+GRA17-HA strains and monitored both
body weight and survival. We found that none of the mice
infected with DGRA17+GRA17-HA or DGRA17+PfEXP2-HA
survived past 12 days post-infection, whereas all of the mice
infected with the DGRA17 or DGRA17/DGRA23+GRA17-HA
strains survived the duration of the experiment (Figure 4B,
top). In contrast to the mice infected with DGRA17 parasites,
those infected with DGRA17/DGRA23+GRA17-HA experi-
enced a significant drop in body weight and deterioration in
body condition (e.g., hunched stance and ruffled fur) during
the course of infection before recovering fully by 30 days
post-infection (Figure 4B, bottom). Thus, PfEXP2 can rescue
the loss of GRA17 in vivo, and the deletion of GRA23 with
low GRA17 expression renders Toxoplasma avirulent. Since
the type I strain is hyper-virulent in mice, we tested the accel-
erated growth in vivo by overexpressing GRA17 in the far less
virulent type III strain (LD50 = 10
5 tachyzoites), which alsonc.
Figure 3. GRA17 Affects the Stability of
Toxoplasma PVs
(A) Sub-confluent HFFs were infected with
DGRA17 tachyzoites and imaged live. Images
obtained by phase contrast microscopy are pre-
sented at 30min time points from 19:30 hr through
25:00 hr post-infection. Matching colored arrow-
heads indicate the collapse of indicated PVs in
consecutive time points (scale bar = 10 mm).
(B) Confluent monolayers of HFFs were infected
with 100 tachyzoites of each indicated strain for
4 days. For every experiment, the area of at least
30 plaques from each strain was measured
(Figure S5A), and the mean area was normalized
to WT. Each bar of the graph represents an
average of means across experimental replicates
(n = 8 for all conditions except for DGRA17+
GRA17-HA, where n = 3). Error bars represent ±
SD, and paired two-tailed t tests were performed
comparing each condition to WT to assess sta-
tistical significance (*** p < 0.0001).accelerated its in vitro growth (Figure S5B). We infected BALB/
c mice with this strain and a WT (type III) strain. We found that
all the infected mice survived, but the mice infected with type
III+GRA17-HA had a higher parasite burden (Figure S5C), lost
more weight (Figure S5D), had a worse body condition (e.g.,
hunched posture and ruffled coat), and had a higher brain tis-
sue cyst count in some but not all of this cohort (Figure S5E).
GRA17 and GRA23 Are Synergistically Required for
Growth
We were able to detect DGRA23 phenotypes only in the back-
ground of significantly reduced GRA17 expression, and the
overexpression of GRA23-HF in the DGRA17 background
was able to partially rescue DGRA17 phenotypes, suggesting
GRA17 and GRA23 operate synergistically. While we were
able to generate multiple, independent clonal tachyzoite iso-Cell Host & Microbe 17, 642–lates of DGRA17/DGRA23+GRA17-HA,
we could not generate a DGRA17/
DGRA23 strain in parallel by multiple
methods. In order to determine whether
a DGRA17/DGRA23 strain is viable,
we used the CRISPR gene disruption
technology developed for Toxoplasma
(Shen et al., 2014; Sidik et al., 2014).
We chose target strains where GRA17-
HA is the only species of GRA17 present
so we could follow its fate by IF
microscopy. As a test, we co-trans-
formed the DGRA17/DGRA23+GRA17-
HA strain with Cas9-3xFLAG, a guide
RNA (gRNA) to target protospacer se-
quences early within the GRA17 coding
sequence as well as a double-stranded
oligonucleotide donor template con-
taining a nonsense mutation near the
predicted Cas9-cleavage site. We co-
transformed donor templates with our
gRNAs, since our target strain back-ground is DKu80, which eliminates non-homologous end-
joining in favor of homologous recombination (Fox et al.,
2009). We used three different gRNA/donor template pairings,
fixed at 24 hr and 48 hr, and observed these gRNAs led to
similar GRA17-HA loss relative to no loss with a non-specific
gRNA (Figures 5A, top panel, and S6).
After transformation of both the DGRA17/DGRA23+GRA17-
HA and DGRA17+GRA17-HA strains with Cas9-3xFLAG,
a GRA17-specific gRNA/donor ([residues 29–36]/donor tem-
plate [Leu32stop]) and subsequent infection of HFFs, we fixed
infected cells early to compare the initial loss of GRA17-HA
signal in the population (24 hr) to late, when the parasites
will form plaques in the host cell monolayer (120 hr). Both
target strains were transformed at an equivalent rate as
measured by Cas9-3xFLAG detection (27%–28%; Figure 5B,
top panel). We also found that DGRA17+GRA17-HA and652, May 13, 2015 ª2015 Elsevier Inc. 647
Figure 4. GRA17 Affects the Virulence and
In Vivo Proliferation of Toxoplasma
(A) Cohorts of five female CD-1 mice (aged 6–
8 weeks) were each infected with 100 tachyzoites
(one additional cohort was infected with 1,000
tachyzoites of DGRA17) i.p. with each type I (RH)
strain and survival was monitored. At day 30, the
surviving DGRA17 mice from the 100 tachyzoites
infection were re-infected with 104 WT tachyzoites,
and survival was monitored (arrow).
(B) Infection of mice was carried out as above, and
survival was monitored for 34 days post-infection
(top panel). The mice were weighed throughout the
infection and plotted as an average of the change in
body weight for each cohort, where 100% body
weight is the day before infection (bottom panel).
Error bars indicate +SD, and single asterisks indi-
cate p < 0.05 statistical significance assessed
at that time point compared to DGRA17 by a
Student’s t test.DGRA17/DGRA23+GRA17-HA had comparable loss of
GRA17-HA signal at 24 hr post-infection (23% and 26% out
of the total population, respectively; Figure 5B, top panel). By
contrast, we found that 6.6% (of 584 total plaques scored) of
the DGRA17+GRA17-HA plaques were GRA17-HA negative
at 120 hr post-infection compared to 0% (of 934 plaques
scored) in the DGRA17/DGRA23+GRA17-HA strain (p <
0.0001; Figures 5A, bottom panel, and 5B, bottom panel). In
parallel, we serially diluted the transformants into HFFs to
isolate tachyzoite clones: 2/20 clones from the DGRA17+
GRA17-HA strain were GRA17-HA negative compared to 0/
120 clones from the DGRA17/DGRA23+GRA17-HA strain.
Taken together, our results strongly indicate that GRA17 and
GRA23 are synergistically required for Toxoplasma growth.
GRA17 and GRA23 Alter the Membrane Conductance of
Xenopus Oocytes
We expressed GRA17 and GRA23 in Xenopus oocytes to see
if they can alter membrane permeability consistent with the
insertion of large, relatively non-selective pores into the cell
membranes. The expression of such a non-selective poremakes
several experimentally testable predictions. The first is that
expression will be detrimental to cells, resulting in significant
cell death due to loss of cell contents and inability to maintain
volume homeostasis. When varying levels of GRA17 and
GRA23 cRNAs were injected into Xenopus oocytes, a dose-
dependent increase in cell lysis was observed relative to water-
injected cells or to GRA15 cRNA, a GRA protein that localizes to
the PVM (Rosowski et al., 2011) but which is not predicted to
affect membrane permeability (Figure 6A). HA-tagged versions
of GRA17, GRA23, and GRA15 were detected in total membrane
fractions isolated from cRNA-injected oocytes (Figures S7A and
S7B), and GRA17 and GRA23 were also observed localized to
the oocyte plasma membrane in fixed histology sections (Fig-
ure S7C). The second prediction is that increased membrane
permeability through expression of putative non-selective pores
would cause a depolarizing shift in membrane resting potential
prior to cell lysis, and GRA17 and GRA23 both demonstrated
this shift relative to water- or GRA15-injected oocytes (Fig-
ure 6B). Finally, the current to voltage relationship of the net648 Cell Host & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Imembrane current for a large non-selective, constitutively
open pore should result in an increased linear current-voltage
relationship (Figure 6C), a depolarization of the reversal potential
(‘‘Vrev’’; Figure 6D, top panel), and an increased conductance
(‘‘G’’; Figure 6D, bottom panel) for GRA17 and GRA23 relative
to water- or GRA15-injected oocytes, which we observed. The
results of these exogenous expression studies are strongly
consistent with the hypothesis that GRA17 and GRA23 can
form non-selective high-conductance pores when exogenously
expressed in cell membranes. We injected a separate batch
of Xenopus oocytes with PfEXP2-HA cRNA and, as with the
Toxoplasma GRAs, found that it was present in total membrane
and cytosolic fractions (Figure S7D). Relative to GRA17 and
GRA23, PfEXP2 cRNA-injected oocytes had a more modest
decrease in survival (73% compared to 93% of water-injected
oocytes; Figure S7E). There was no statistically significant
difference between PfEXP2 cRNA-injected oocytes and water-
injected control resting membrane potential (RMP) (Figure S7F);
however, the control oocytes had a significantly depolarized
RMP compared to the previous batches of oocytes used for
the Toxoplasma GRAs (Figure 6B), making direct comparison
difficult. We did observe a statistically significant increased
conductance (G) change in PfEXP2 cRNA-injected oocytes (Fig-
ures S7G and S7H), which is consistent with PfEXP2 forming a
large membrane pore. Further work is needed to characterize
the role of PfEXP2 as a membrane pore.
DISCUSSION
Intracellular pathogens that reside within vacuoles face a chal-
lenge of scavenging nutrients and modulating the host cell
beyond their vacuole membrane. The existence of putative
pores providing selective permeability to small molecules in
the Toxoplasma and Plasmodium PVMs had been described
(Desai and Rosenberg, 1997; Schwab et al., 1994), and now
we have provided a molecular basis for this phenomenon in
any Apicomplexa. The flow of small molecules between the
host cytosol and PV plays a critical role in tachyzoite growth
and survival, and its reduction may result in either restriction to
nutrients or the inability of toxic metabolic byproducts to effluxnc.
Figure 5. GRA17 and GRA23 Are Synergisti-
cally Required for Growth
(A) Confluent HFFs were infected with DGRA17/
DGRA23+GRA17-HA or DGRA17+GRA17-HA
parasites that were transiently co-transformed
with Cas9-3xFLAG and either non-specific or
GRA17-specific gRNAs along with GRA17 donor
oligonucleotide templates containing a nonsense
mutation. The infected cells were fixed at 24 hr,
48 hr, or 120 hr at different MOIs and subjected
to IFA with anti-HA and anti-FLAG antibodies
(sample image, top left panel; scale bar = 10 mm) or
anti-HA and anti-SAG1 antibodies (sample image,
bottom left panel; scale bar = 25 mm). White
asterisks indicate vacuoles where HA-signal is
absent. The dashed line distinguishes between the
two plaques.
(B) The percentage of Cas9-3xFLAG-positive
vacuoles and GRA17-HA-positive vacuoles out
of the total were scored and averaged (top). In
total, 750 vacuoles each were scored across three
experimental replicates. The percentage of Cas9-
3xFLAG-positive plaques andGRA17-HA-positive
plaques out of the total were scored and averaged
(bottom panel). The number, n, over each bar
graph refers to the total number of plaques scored
in total for each condition across three experi-
mental replicates. Error bars represent ± SD.
Statistical significance was determined using a
two-tailed Fisher’s exact test comparing the total
number of HA-negative vacuoles and plaques for
both conditions (***p < 0.0001).out of the PV. Overexpressing GRA17 leads to more rapid
growth, suggesting that nutrients scavenged by Toxoplasma
via GRA17 may be limiting factors for normal growth of the
parasite.
An important question is how the DGRA17 strain remains
viable in vitro when it is starved from access to small molecules.
A hint as to why some parasites retain viability lies in the aberrant
morphology of the DGRA17 PVs. The tachyzoites within the
enlarged vacuoles are viable as they replicate and egress. The
aberrant PVs may then be the byproduct or consequence of a
compensatory mechanism for GRA17 absence. Compensation
may include a change in the osmolarity or other structural forces,
resulting in PV enlargement. The collapsed PVs may be due to
ineffective compensation to reduced access to small molecules
or to overcompensation that leads to PV damage. PV collapse,
as well as the sensitivity of the enlarged PVs to fixatives, hints
at the dynamism and fragility of the DGRA17 PVs and implies a
precarious balance of compensatory forces.
A prime candidate for a compensatory molecule is GRA23
based on the body of evidence we have presented. One model
is that GRA17 and GRA23 may form a variety of homo- or
hetero-multimers whose biophysical properties may differ de-
pending on the composition of the complex. Alternatively,
GRA17 and GRA23 may function on the PVM separately, as
monomers or otherwise, having partially overlapping but ulti-
mately separable functions. GRA17 and GRA23 may functionCell Hsimilarly to a-helical pore-forming molecules like colicins or
the pro-apoptotic protein Bax that can exist in either a water-
soluble state or as an integral membrane pore that alters perme-
ability (reviewed in Parker and Feil, 2005). Particularly intriguing
are Bax-derived small a-helical peptides that can homo-multi-
merize within the membrane via a toroidal mechanism that
does not require direct protein-protein interactions but instead
contains proteins interspersed with lipids (Garcı´a-Sa´ez et al.,
2006; Qian et al., 2008). We have immunoprecipitated both
GRA17 and GRA23 from PVM-containing fractions in the cell
(data not shown), but we have so far not been able to identify
specific interacting proteins. Our mRNA sequencing experiment
did identify several other genes encoding putatively secreted
protein products that are uniquely upregulated in the DGRA17
strain, but none of these have been functionally characterized
to date. Thus, future work is required to define the exact molec-
ular functions of GRA17 and GRA23 as well as identify associ-
ated molecular factors.
The observation that Plasmodium EXP2 can rescue DGRA17
phenotypes hints at a possible role of GRA17 or GRA23 in
protein export in Toxoplasma. However, GRA16 and GRA24
accumulation in the host nucleus via post-invasion in both the
DGRA17 and DGRA23 strains argues against such a role,
although GRA17 and GRA23 may have redundant functions in
protein export. It will be difficult to distinguish between a poten-
tial defect in export in the absence of both proteins versusost & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Inc. 649
Figure 6. GRA17 or GRA23 Alter the Mem-
brane Conductance Properties of Xenopus
Oocytes
(A) Percentage survival of Xenopus laevis oocytes
injected with indicated amounts of mRNA or H2O in
a dose-dependent manner 3 days post-injection.
Survival was based on a morphological appear-
ance of the oocytes. Fractions on top of each bar
graph represent the number of oocytes that sur-
vived out of the total injected.
(B) Average RMPs of surviving oocytes.
(C) Average membrane currents measured from a
holding potential of 90 mV potentials of 120 mV
to +50 mV were applied for 2 s. Peak currents from
each applied voltage were used to generate an I-V
relationship.
(D) Average conductance (G, bottom) and the
reversal potential (Vrev, top) were computed by
fitting the I-V relationship as a straight line. For all
above sub-figures, data are shown as the mean ±
SE. Confidence levels were calculated using Stu-
dent’s paired t test, where * signifies p < 0.05 when
compared to H2O-injected oocytes and # signifies
p < 0.05 when compared to GRA15-injected
oocytes.parasites that are dead or dying and thus unable to actively
export protein. Ultimately, very little is known about Toxoplasma
protein export, and there are currently only two reported ex-
ported proteins to test as candidates. Even though Plasmodium
EXP2 has not been formally shown to be the translocation pore
for protein export, it begs the question of whether it serves a
dual role of nutrient pore and protein channel, since EXP2 is
the only GRA17-like protein in Plasmodium spp. The aforemen-
tioned a-helical pore-forming proteins can form pores big
enough for peptides in many cases (Parker and Feil, 2005), sug-
gesting this dual functionality is feasible. It is possible that the
other proteins in the PTEX complex may direct the function of
EXP2 from a potential nutrient pore toward a role in protein
export.
GRA17 and GRA23 may help elucidate another longstanding
question of Toxoplasma biology concerning the sporozoite, the
sexually derived stage found in the oocyst. After excystation
from the oocyst and invasion of the host cell, the sporozoite
forms a unique vacuole (PV1) in which the sporozoite un-
dergoes no replication and ultimately egresses from the PV1
to form a second vacuole (PV2) in the same cell where it com-
pletes its conversion to the tachyzoite stage and undergoes
replication. Unlike tachyzoite PVs and PV2, the PV1 is imper-
meable to small molecules and devoid of a subset of GRAs
typically associated with PV ultrastructure, suggesting that
GRA proteins play a role in this process (Speer et al., 1995).
The PV1 has a strikingly enlarged morphology similar to the
DGRA17 PV, and neither GRA17 nor GRA23 are expressed in
the oocyst stage (Fritz et al., 2012), implying the possibility650 Cell Host & Microbe 17, 642–652, May 13, 2015 ª2015 Elsevier Inc.that their absence plays a role in the
unique properties of the sporozoite PV1.
We believe GRA17 and GRA23 present
exciting tools to understand the challenge
of how pathogens proliferate within anintracellular vacuole, which is a phenomenon widely conserved
in pathogens across evolution.
EXPERIMENTAL PROCEDURES
Reagents
5-(and-6)-carboxy-20,70-dichlorofluorescein diacetate (C-369) and Dextran
3000-Alexa488 (D34682) were obtained from Life Technologies and lucifer
yellow CH dipotassium salt (L0144) from Sigma-Aldrich.
Parasite and Cell Culture and Plaque Size Assays
Toxoplasma tachyzoites and HFFs maintenance and plaque size assays were
performed as described (Rosowski et al., 2011).
Transient Transformation and Cas9-Mediated Gene Disruption
DNA sequences targeting GRA17 were cloned into the pSS013 Cas9 vector
(Sidik et al., 2014) as described in Supplemental Experimental Procedures.
Transient transformations of the pSS013 plasmid were performed by
co-electroporating 50–100 mg of circular DNA per strain and 25 ml of
pre-annealed donor template oligonucleotides (100 mM) into freshly scrape-
syringe-lysed tachyzoites, as described in Supplemental Experimental Proce-
dures, and used to infect HFFs immediately. Confluent HFFs on coverslips
were infected for fixation at 24 hr, 48 hr, and 120 hr at MOIs of 2, 0.5, and
0.04, respectively; fixed; and processed for IFA. For cloning purposes, trans-
formed parasites were serially diluted into HFFs grown on 96-well plates
without selection. Single-plaque wells were replica-passaged for propagation
or for IFA with anti-HA antibodies to determine whether GRA17-HA was
disrupted.
Microscopy of Fixed Samples
Microscopy was performed with NIS-Elements software (Nikon) and a digital
camera (CoolSNAP EZ; Roper Scientific) connected to an inverted fluores-
cence microscope (eclipse Ti-S; Nikon) and either phase contrast or DIC
imaging. Deconvolution imaging was performed using the OptiGrid Structured
Light Imaging System (QIOPTIQ Imaging Solutions).
Cell Fractionation
Membrane enriched fractions of infected HFFs were obtained by mechanical
lysis and differential centrifugation and treated with 0.1 M sodium carbonate
(pH 11) or PBS as described (Sibley et al., 1995). The resulting pellet and
supernatant were subjected to SDS-PAGE and western blotting.
Live Microscopy
HFFs were grown on glass-bottom 24-well plates (Greiner Bio-One) and
infected with tachyzoites for 24 hr in growth media. The cells were washed
with PBS and replaced with growth media minus phenol red (GMPR) supple-
mented with 10 mM CDCFDA for 10 min at 37C. CDCFDA was sequentially
diluted into GMPR from a 10 mM DMSO solution. The dye-containing media
was removed, and the cells were washed three times with PBS, replaced
with GMPR, and were immediately imaged. Scrape-loading experiments
were modified from el-Fouly et al. (1987). Briefly, infected cells were prepared
as above on glass bottom 24-well plates. Either 0.5 mM lucifer yellow CH or
0.5 mg/ml Dextran3000-Alexa488 were diluted in GMPR and incubated for
5 min at 37C. The disposable tip of a 10 ml pipette was used to scape a criss-
crossed series of straight lines on the bottom of the well. The cells were
washed three times with PBS, replaced with GMPR, and were immediately
imaged. For the extended time course experiments, HFFs were infected with
the DGRA17 strain. Cells were imaged every 30 min over a 72 hr period using
a 403 objective (NA = 0.95) on a Nikon TE2000 inverted microscope equipped
with an environmental chamber, Hamamatsu ORCA-ER digital camera, and
NIS Elements Imaging Software.
Mouse Survival and Physiology
Formouse infection, infected HFFsweremechanically lysedwith 30G needles,
washed with PBS, and centrifuged at 993 g for 5min to pellet any intact HFFs.
The supernatant was subsequently centrifuged at 582 3 g for 7 min to collect
tachyzoites and then diluted in PBS and counted. For the survival assays,
5 female CD-1mice (age 6–8 weeks, Charles River Laboratories) were infected
i.p. with 100 tachyzoites per each strain (plus a cohort of mice was infected
with 1,000 tachyzoites of DGRA17). Surviving mice were re-infected i.p. at
day 30 post-infection with 10,000 tachyzoites of WT andmonitored for survival
for an additional 21 days. For all infections, relative parasiteMOI was assessed
by plaque assays, and all surviving mice were verified to be seropositive
for Toxoplasma antigen. Mice below a body condition score of 2 were eutha-
nized and counted as dead in accordance with institutional and federal
regulations. All mice were maintained in specific pathogen-free conditions.
TheMIT Committee on Animal Care approved all protocols (assurance number
A-3125-01).
Electrophysiology
Xenopus laevis were cared for according to standards approved by the Insti-
tutional Animal Care and Use Committee of the University at Buffalo. The frogs
were anesthetized in tricaine (1 g/l; Sigma). Oocytes were digested in 82.5 mM
NaCl, 2 mM KCl, 1 mM MgCl2, 5 HEPES (pH 7.4), 1 mg/ml collagenase, and
type I (Sigma) and shaken for 1.5 to 2 hr. Oocytes (stages V–VI) were injected
with <50 ng mRNA (Nanoject; Drummond Scientific). cRNA preparation is
described in Supplemental Experimental Procedures. Oocytes were voltage-
clamped at room temperature with a two-electrode clamp (CA-1B; Dagan).
Microelectrodes (resistances: 0.5–1.5 MU) were fabricated from 1.5 mm o.d.
borosilicate glass tubing (TW150-4; WPI) using a two-stage puller and filled
with 3 M KCl. The control extracellular solution (ND96) contained (mM) 96
NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, and 10 HEPES (pH 7.4). Data were digitized
and analyzed using pCLAMP (Axon). Further analysis was performed using
Clampfit (Axon), Excel (Microsoft), and Origin (OriginLab). Data were filtered
at 2 kHz.
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